Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Internal Medicine Journal
|
July 2, 2020
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience
Aditya Tedjaseputra, Michael Gilbertson, Michael Low, et al.
Ejhaem
|
August 21, 2025
Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse
Mark Waltham, Jonathan Wong, Galina Polekhina, et al.
Pathology
|
April 5, 2024
Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study
Aditya Tedjaseputra, Sukanya Roy, Kay Htun, et al.
Leukemia & Lymphoma
|
June 21, 2022
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic
Aditya Tedjaseputra, James A Kuzich, Nisha Thiagarajah, et al.
Blood Advances
|
September 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML
Nigel Russell, Jad Othman, Oliver Cumming, et al.
Internal Medicine Journal
|
March 7, 2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, et al.
Blood Advances
|
September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
Ing S Tiong, Richard Dillon, Adam Ivey, et al.
Blood Advances
|
September 8, 2022
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
Harry J Iland, Nigel Russell, Richard Dillon, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Responses
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Summary
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Internal Medicine Journal
|
July 2, 2020
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience
Aditya Tedjaseputra, Michael Gilbertson, Michael Low, et al.
Ejhaem
|
August 21, 2025
Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse
Mark Waltham, Jonathan Wong, Galina Polekhina, et al.
Pathology
|
April 5, 2024
Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study
Aditya Tedjaseputra, Sukanya Roy, Kay Htun, et al.
Leukemia & Lymphoma
|
June 21, 2022
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic
Aditya Tedjaseputra, James A Kuzich, Nisha Thiagarajah, et al.
Blood Advances
|
September 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML
Nigel Russell, Jad Othman, Oliver Cumming, et al.
Internal Medicine Journal
|
March 7, 2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, et al.
Blood Advances
|
September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
Ing S Tiong, Richard Dillon, Adam Ivey, et al.
Blood Advances
|
September 8, 2022
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
Harry J Iland, Nigel Russell, Richard Dillon, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Responses
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Summary
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Page
of 3